Valuation: Cogstate Limited

Market Cap 576M 403M 360M 330M 300M 563M 38.13B 3.94B 1.58B 20.18B 1.51B 1.48B 63.93B P/E 2027 *
26.6x
P/E 2028 * 20.6x
Enterprise Value 511M 358M 319M 293M 266M 500M 33.84B 3.5B 1.4B 17.91B 1.34B 1.32B 56.74B EV / Sales 2027 *
4.7x
EV / Sales 2028 * 3.95x
Free-Float
56.72%
Yield 2027 *
1.49%
Yield 2028 * 1.82%
1 day+0.90%
1 week-0.88%
Current month-2.03%
1 month+1.20%
3 months+30.00%
6 months+45.69%
Current year+49.56%
1 week 3.29
Extreme 3.29
3.46
1 month 3.23
Extreme 3.23
3.98
Current year 2.01
Extreme 2.01
3.98
1 year 1.75
Extreme 1.75
3.98
3 years 0.8
Extreme 0.795
3.98
5 years 0.8
Extreme 0.795
3.98
10 years 0.16
Extreme 0.155
3.98
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1999-12-16
Chief Executive Officer - 2005-11-30
Director of Finance/CFO - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2011-02-28
Chairman 67 2009-11-02
Director/Board Member - 2017-01-19
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/26 Buy

Director

3,600 0.0021%
5/20/26 Buy

Director

430 0.0003%
4/15/26
Myer & Myer Pty Ltd.
SellCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
+0.90%-0.88%+22.02%+124.58% 403M
+10.00%+4.50%+58.63%+71.20% 66.87B
+1.44%+5.05%+22.52%+101.03% 56.55B
+3.32%+2.31%+11.04%+75.04% 57.2B
+0.46%-5.47%+25.04%+33.77% 43.47B
+2.82%+5.82%+240.96%+801.17% 42.8B
+6.42%+1.18%+22.18%+105.56% 42.95B
-3.79%-7.50%+89.46%+77.13% 32.11B
+5.32%+5.37%+19.12%+52.98% 34.01B
+5.32%+13.43%-39.82%+342.66% 24.13B
Average +3.22%+2.17%+47.12%+178.51% 40.05B
Weighted average by Cap. +3.86%+2.57%+51.81%+168.94%

Financials

2027 *2028 *
Net sales 109M 76.19M 67.89M 62.26M 56.58M 106M 7.2B 744M 298M 3.81B 286M 280M 12.07B 125M 87.61M 78.07M 71.6M 65.07M 122M 8.28B 856M 343M 4.38B 329M 322M 13.88B
Net income 21.75M 15.23M 13.58M 12.45M 11.31M 21.27M 1.44B 149M 59.65M 762M 57.18M 55.96M 2.41B 27.77M 19.45M 17.33M 15.89M 14.44M 27.15M 1.84B 190M 76.15M 973M 73.01M 71.44M 3.08B
Net Debt -64.78M -45.36M -40.42M -37.07M -33.69M -63.33M -4.29B -443M -178M -2.27B -170M -167M -7.19B -82.32M -57.64M -51.37M -47.11M -42.81M -80.48M -5.45B -563M -226M -2.88B -216M -212M -9.13B
Projected Income Statement - Annual - Cogstate Limited
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
26-11-05 A$3.380 +0.90% 199,549
26-11-04 A$3.350 -0.59% 275,433
26-11-03 A$3.370 -0.59% 464,738
26-11-02 A$3.390 -1.74% 230,550
26-10-30 A$3.450 +1.17% 206,001
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Cogstate Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.350AUD
Average target price
4.497AUD
Spread / Average Target
+34.23%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cogstate Limited